MGRM(Delisted)
Monogram·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 0
Bearish signal 2
Hanging Man
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About MGRM
Monogram Technologies Inc.
A company focused on developing product solution architectures to enable large-scale personalized optimization of orthopedic implants
3913 Todd Lane, Austin, Texas 78744
--
Monogram Technologies Inc., was incorporated in Delaware on April 21, 2016. The company is working on developing a product solution architecture with the long-term goal of enabling patient-optimized orthopedic implants at economies of scale by combining 3-D printing and robotics with advanced preoperative imaging. The company has a robotic prototype that autonomously executes optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram intends to produce and sell robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables and miscellaneous instruments for reconstructive joint replacement surgery.
Earnings Call
Q1/2025
Estimate EPS-0.12
Actual EPS-0.1
Estimate Revenue--
Actual Revenue0
Monogram Technologies' Q1 2025: Navigating Conflicting Timelines and Cost Strategies in Earnings Call
May 20,2025 06:51
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
MGRM has released its 2025 Q2 earnings. EPS was reported at -0.16, versus the expected -0.09, missing expectations. The chart below visualizes how MGRM has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
